FDA removes hold on three CARsgen CAR-T trials; Ono passes on itolizumab

Plus, news about Kymera Therapeutics, Nanoscope, Eupraxia, Alpha Cognition and EyePoint: FDA's decision on CARsgen’s CAR-T therapies: The FDA on Thursday lifted a clinical hold on three of CARsgen Therapeutics’ CAR ...